91 related articles for article (PubMed ID: 26995008)
1. Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.
Li CE; Chien CS; Chuang YC; Chang YI; Tang HP; Kang CH
Int Urol Nephrol; 2016 Jun; 48(6):993-9. PubMed ID: 26995008
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative pyuria & neutrophil to lymphocyte ratio in patients with non-muscle-invasive bladder cancer: A prospective cohort study.
Singh R; Sharma G; Priyadarshi S; Fauzdar G
Urologia; 2024 Feb; 91(1):69-75. PubMed ID: 37909427
[TBL] [Abstract][Full Text] [Related]
3. Areca Nut Chewing and an Impaired Estimated Glomerular Filtration Rate as Significant Risk Factors for Non-Muscle-Invasive Bladder Cancer Recurrence.
Cao J; Xu R; Zhao X; Zhong Z; Zhang L; Zhu X; Wu S; Ai K
Sci Rep; 2016 Jul; 6():29466. PubMed ID: 27385379
[TBL] [Abstract][Full Text] [Related]
4. Environmental and occupational exposures and prognosis in patients with non-muscle-invasive bladder cancer in the Be-Well Study.
Wang Z; Kwan ML; Haque R; Pratt R; Lee VS; Roh JM; Ergas IJ; Cannavale KL; Loo RK; Aaronson DS; Quesenberry CP; Ambrosone CB; Kushi LH; Tang L
Am J Epidemiol; 2024 Jun; 193(6):863-873. PubMed ID: 38055616
[TBL] [Abstract][Full Text] [Related]
5. Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of high-grade T1 bladder cancer.
Silva Medeiros M; Botelho de Carvalho LA; Alves M; Papoila A; Baptista Carreira Dos Santos HM; Capelo-Martínez JL; Viegas de Campos Pinheiro LM
Int Urol Nephrol; 2024 Mar; ():. PubMed ID: 38530585
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
Kobatake K; Hayashi T; Black PC; Goto K; Sentani K; Kaneko M; Yasui W; Mita K; Teishima J; Matsubara A
Int J Urol; 2017 Aug; 24(8):594-600. PubMed ID: 28734027
[TBL] [Abstract][Full Text] [Related]
7. Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.
Chien CS; Luo HL; Ling CS; Chiang PH; Chen YT; Cheng YT
Int Urol Nephrol; 2016 Aug; 48(8):1261-1265. PubMed ID: 27193437
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes.
Li H; Wang L; Li H; Zhang P; Li Z; Xue L; Wang Z; Fu D; Chen Q; Luo Q; Chong T; Wang Z
Oncology; 2024; 102(4):337-342. PubMed ID: 37647883
[TBL] [Abstract][Full Text] [Related]
9. Effect of decreased renal function on poor oncological outcome after radical cystectomy.
Kim D; Nam W; Kyung YS; You D; Jeong IG; Hong B; Hong JH; Ahn H; Lim B
Investig Clin Urol; 2023 Jul; 64(4):346-352. PubMed ID: 37417559
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and risk factors for 30-day mortality in esophageal cancer patients with upper gastrointestinal bleeding: a multicenter study.
Lu SW; Pai CP; Yang TH; Lu JX; Hsiao CH; Yen CC
Front Oncol; 2023; 13():1184710. PubMed ID: 37213275
[TBL] [Abstract][Full Text] [Related]
11. Pre‑existing renal insufficiency synchronous with high preoperative neutrophil‑to‑lymphocyte ratio as a risk factor of intravesical recurrence in patients with pure upper tract urothelial carcinoma after radical nephroureterectomy.
Cheng TH; Hu CY; Wu KY; Tai TY; Weng HY; Yang WH; Ou CH; Jan HC
Exp Ther Med; 2022 Nov; 24(5):671. PubMed ID: 36277146
[TBL] [Abstract][Full Text] [Related]
12. Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer.
Fujita N; Hatakeyama S; Momota M; Tobisawa Y; Yoneyama T; Yamamoto H; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
Sci Rep; 2022 Aug; 12(1):13786. PubMed ID: 35962127
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and predictive biomarkers for bladder cancer in patients with type 2 diabetes presenting with haematuria.
Tonry CL; Evans RM; Ruddock MW; Duggan B; McCloskey O; Maxwell AP; O'Rourke D; Boyd RE; Watt J; Reid CN; Curry DJ; Stevenson M; Young MK; Jamison CS; Gallagher J; Fitzgerald SP; Lamont J; Watson CJ
Diabetes Metab Res Rev; 2022 Sep; 38(6):e3546. PubMed ID: 35578575
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators.
Russell B; Häggström C; Holmberg L; Liedberg F; Gårdmark T; Bryan RT; Kumar P; Van Hemelrijck M
BJUI Compass; 2021 May; 2(3):140-158. PubMed ID: 35475135
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of the Anesthetic Methods for Recurrence Rates of Bladder Cancer after Transurethral Resection of Bladder Tumors Using National Health Insurance Claims Data of South Korea.
Lee SW; Tae BS; Choi YJ; Yoon SM; Lee YS; Kim JH; Shin HW; Park JY; Bae JH
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207416
[TBL] [Abstract][Full Text] [Related]
16. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.
Chinnadurai R; Clarke NW; Kalra PA
BMC Nephrol; 2020 May; 21(1):202. PubMed ID: 32471368
[TBL] [Abstract][Full Text] [Related]
17. The significance of preoperative estimated glomerular filtration rate on survival outcomes in patients who underwent radical cystectomy and non-continent urinary diversion.
Sefik E; Celik S; Gunlusoy B; Basmaci I; Bozkurt IH; Degirmenci T
Int Braz J Urol; 2020; 46(4):566-574. PubMed ID: 32213208
[TBL] [Abstract][Full Text] [Related]
18. A population-based cohort study examining the association of documented bladder diverticulum and bladder cancer risk in urology patients.
Fang CW; Hsieh VC; Huang SK; Tsai IJ; Muo CH; Wu SC
PLoS One; 2019; 14(10):e0222875. PubMed ID: 31613877
[TBL] [Abstract][Full Text] [Related]
19. The association of preoperative reduced glomerular filtration rate with higher staging and histology grades in patients with urinary tract cancers.
Premuzic V; Hudolin T; Penezic L; Golubic I; Gamulin M; Jelakovic B; Kastelan Z
Int Urol Nephrol; 2019 Sep; 51(9):1537-1544. PubMed ID: 31240530
[TBL] [Abstract][Full Text] [Related]
20. The clinicopathological characteristics and prognostic value of squamous differentiation in patients with bladder urothelial carcinoma: a meta-analysis.
Lin X; Deng T; Wu S; Lin SX; Wang D; Wu CL
World J Urol; 2020 Feb; 38(2):323-333. PubMed ID: 31011874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
